Home / Import refusals / AEK-8550483-3/11/1

AEK-8550483-3/11/1

Novo Nordisk Inc. — FEI 2244771

Recent inspections

  • 1255957 (OAI Fri Feb 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1194065 (NAI Wed Dec 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1013344 (VAI Thu Apr 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 983531 (NAI Fri Jul 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 968597 (NAI Tue Apr 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time))

Compliance actions

Other import refusals

  • 799-9963061-2/10003/1 (Fri Feb 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-9296360-0/10002/1 (Wed Jan 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-9296321-2/10002/1 (Thu Jan 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-0744255-5/10003/1 (Fri Jan 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • SCS-9927209-3/10003/1 (Mon Jan 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

Refusal Details

Date
June 27, 2025
Country
United States
Product Category
Drugs and Biologics
Product Code
61PDY72 SEMAGLUTIDE (ANTI-DIABETIC)
Charges
75